A phenotypic screen of motor neurons derived from induced pluripotent stem cells (iPSCs) from ALS patients with SOD1 mutation revealed that more than half of the tested drugs that stop neuronal cell death target the Src/c-Abl pathway. Here, SOD1 is linked to amyotrophic lateral sclerosis.